Relevant bibliographies by topics / Prevention of pulmonary fibrosis

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Prevention of pulmonary fibrosis'

Author: Grafiati
Published: 4 June 2021
Last updated: 5 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Prevention of pulmonary fibrosis.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Prevention of pulmonary fibrosis"

1

Lommatzsch, Sherstin T. "Infection prevention and chronic disease management in cystic fibrosis and noncystic fibrosis bronchiectasis." Therapeutic Advances in Respiratory Disease 14 (January 2020): 175346662090527. http://dx.doi.org/10.1177/1753466620905272.

Full text
Abstract:
Bronchiectasis is a chronic lung disease (CLD) characterized by irreversible bronchial dilatation noted on computed tomography associated with chronic cough, ongoing viscid sputum production, and recurrent pulmonary infections. Patients with bronchiectasis can be classified into two groups: those with cystic fibrosis and those without cystic fibrosis. Individuals with either cystic fibrosis related bronchiectasis (CFRB) or noncystic fibrosis related bronchiectasis (NCFRB) experience continuous airway inflammation and suffer airway architectural changes that foster the acquisition of a unique p
APA, Harvard, Vancouver, ISO, and other styles
2

Chedevergne, Frédérique, and Isabelle Sermet-Gaudelus. "Prevention of osteoporosis in cystic fibrosis." Current Opinion in Pulmonary Medicine 25, no. 6 (2019): 660–65. http://dx.doi.org/10.1097/mcp.0000000000000624.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Slae, Mordechai, and Michael Wilschanski. "Prevention of malnutrition in cystic fibrosis." Current Opinion in Pulmonary Medicine 25, no. 6 (2019): 674–79. http://dx.doi.org/10.1097/mcp.0000000000000629.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Yao, Chu-Fang. "Prevention and treatment of pulmonary-fibrosis by traditional Chinese medicine." Journal of Chinese Integrative Medicine 1, no. 3 (2003): 234–38. http://dx.doi.org/10.3736/jcim20030327.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Kishaba, Tomoo. "Acute Exacerbation of Idiopathic Pulmonary Fibrosis." Medicina 55, no. 3 (2019): 70. http://dx.doi.org/10.3390/medicina55030070.

Full text
Abstract:
Idiopathic pulmonary fibrosis (IPF) is the most common form of idiopathic interstitial pneumonia. Idiopathic pulmonary fibrosis is often seen in elderly men who smoke. A diagnosis of IPF is based on a combination of a detailed clinical history, specific physical examination, laboratory findings, pulmonary function tests, high-resolution computed tomography (HRCT) of the chest, and histopathology. Idiopathic pulmonary fibrosis has a heterogeneous clinical course, from an asymptomatic stable state to progressive respiratory failure or acute exacerbation (AE). Acute exacerbation of IPF has severa
APA, Harvard, Vancouver, ISO, and other styles
6

Havermans, Trudy, and Lore Willem. "Prevention of anxiety and depression in cystic fibrosis." Current Opinion in Pulmonary Medicine 25, no. 6 (2019): 654–59. http://dx.doi.org/10.1097/mcp.0000000000000617.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

van der Meer, Renske, Daan J. Touw, and Harry G. M. Heijerman. "Prevention of drug-related complications in cystic fibrosis." Current Opinion in Pulmonary Medicine 25, no. 6 (2019): 666–73. http://dx.doi.org/10.1097/mcp.0000000000000625.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Bell, S. C., and P. J. Robinson. "Exacerbations in cystic fibrosis: 2 {middle dot} Prevention." Thorax 62, no. 8 (2007): 723–32. http://dx.doi.org/10.1136/thx.2006.060897.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Avdeev, S. N. "Acute exacerbation of idiopathic pulmonary fibrosis." Russian Pulmonology 28, no. 4 (2018): 469–82. http://dx.doi.org/10.18093/0869-0189-2018-28-4-469-482.

Full text
Abstract:
Acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) is defined as an acute clinically significant respiratory deterioration characterized by evidence of new, widespread alveolar abnormalities, such as diffuse bilateral ground-glass opacification and/or consolidation, and the absence of other obvious clinical causes like fluid overload, left heart failure, or pulmonary embolism, etc. AE-IPF is subcategorized as “triggered” (where specific causes are identified, for example, infections, surgery procedures, drug toxicity, etc.) or “idiopathic” (where no specific causes are identified). I
APA, Harvard, Vancouver, ISO, and other styles
10

Smyth, Alan. "Multiresistant pulmonary infection in cystic fibrosis—prevention is better than cure." Lancet 366, no. 9484 (2005): 433–35. http://dx.doi.org/10.1016/s0140-6736(05)67037-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Prevention of pulmonary fibrosis"

1

Choi, Seojin. "Flaxseed oil and prevention of pulmonary fibrosis." Diss., Kansas State University, 2012. http://hdl.handle.net/2097/15106.

Full text
Abstract:
Doctor of Philosophy<br>Department of Human Nutrition<br>Richard C. Baybutt<br>Weiqun George Wang<br>Although omega-3 fatty acids have been a hot issue in nutrition for years, there remains a paucity of research on the topic of omega-3 fatty acid and pulmonary fibrosis and the mechanism is still unclear. The purpose of this research is to investigate the preventive effects of flaxseed oil for bleomycin-induced pulmonary fibrosis in rats and to find the possible underlying mechanisms. There are two experiments demonstrated in this dissertation, one is with various doses of flaxseed oil in
APA, Harvard, Vancouver, ISO, and other styles
2

Jenkins, Richard Gisli. "Upregulation of cyclooxygenase-2 gene expression as a potential means of preventing pulmonary fibrosis." Thesis, University College London (University of London), 2002. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.272417.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Fahim, Ahmed. "The pathogenesis of idiopathic pulmonary fibrosis." Thesis, University of Hull, 2011. http://hydra.hull.ac.uk/resources/hull:5296.

Full text
Abstract:
Idiopathic pulmonary fibrosis (IPF) is a restrictive pulmonary disorder of unknown aetiology with a relentless disease course and a median survival of 3 years after the diagnosis. It is the most common idiopathic interstitial lung disease (ILD) with a basal and peripheral predominance associated with temporal and geographical heterogeneity. As the pathogenesis of this disease is poorly understood, the aim of this work was to investigate the pathobiology of IPF in a prospective manner. There is evidence of a strong association of gastro-esophageal reflux and vascular disease with IPF. Moreover,
APA, Harvard, Vancouver, ISO, and other styles
4

Renzoni, Elisabetta Augusta. "Fibroblast gene expression in pulmonary fibrosis." Thesis, Imperial College London, 2008. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.490948.

Full text
Abstract:
Background: Idiopathic pulmonary fibrosis (IPF) has a median survival since diagnosis of2-3 years. Interstitial lung disease associated with systemic sclerosis (SSc-ILD) is characterised by a better survival than IPF. Lung fibroblasts are the main cell type responsible for the excessive extracellular matrix synthesis in lung fibrosis. The pathogenesis offibrosis in both conditions is largely unknown, and it is unclear to what extent it differs between the two. Hypothesis: The gene expression profile of fibroblasts from IPF and SSc-ILD differs from control lung fibroblasts; significant differen
APA, Harvard, Vancouver, ISO, and other styles
5

Patte, Cécile. "Personalized pulmonary mechanics : modeling, estimation and application to pulmonary fibrosis." Thesis, Institut polytechnique de Paris, 2020. http://www.theses.fr/2020IPPAX076.

Full text
Abstract:
Les poumons réalisent leur fonction vitale d'échanges gazeux grâce notamment à leur élasticité et leur porosité. La fibrose pulmonaire idiopathique (FPI), une maladie pulmonaire interstitielle, impacte fortement la mécanique pulmonaire, soulevant des problématiques cliniques. L'objectif de ce travail est d'améliorer la compréhension et le diagnostic de la FPI en s'appuyant sur une modélisation poromécanique du poumon, personnalisée grâce à des données d'imagerie médicale. Dans une première partie, une analyse bibliographique fait l'état de l'art de la physiologie pulmonaire en relation avec le
APA, Harvard, Vancouver, ISO, and other styles
6

Gibbons, Michael A. "Monocyte and macrophage regulation of pulmonary fibrosis." Thesis, University of Edinburgh, 2010. http://hdl.handle.net/1842/4814.

Full text
Abstract:
In this thesis I examined the role of circulating monocytes and lung macrophages in the pathogenesis of the early fibrotic, progressive fibrotic and resolution phases of pulmonary fibrosis. Pulmonary fibrosis with destruction of lung architecture and consequent respiratory failure and death represents a massive worldwide health burden. Although idiopathic pulmonary fibrosis (IPF) is the archetypal and most common cause of lung fibrosis, numerous respiratory diseases can progress to pulmonary fibrosis, and this usually signifies a worse prognosis. Importantly, the incidence and prevalence of IP
APA, Harvard, Vancouver, ISO, and other styles
7

Berschneider, Barbara. "WISP1 regulation by microRNAs in pulmonary fibrosis." Diss., Ludwig-Maximilians-Universität München, 2014. http://nbn-resolving.de/urn:nbn:de:bvb:19-177835.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Darrah, Rebecca J. "Genetic Modifiers of Cystic Fibrosis Pulmonary Disease." Case Western Reserve University School of Graduate Studies / OhioLINK, 2010. http://rave.ohiolink.edu/etdc/view?acc_num=case1270133199.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Hutchinson, Nicola-Xan. "Studies of cough in Idiopathic Pulmonary Fibrosis." Thesis, Cardiff University, 2016. http://orca.cf.ac.uk/94471/.

Full text
Abstract:
A dry cough is a common symptom described in patients with IPF and impairs quality of life. The exact mechanisms causing cough in IPF remain unclear, however there is evidence that altered cough neurophysiology and sensitisation plays a roleY IPF patients have an enhanced cough reflex sensitivity to the inhalation of capsaicin. It was hypothesised that IPF patients have increased airway expression of the capsaicin receptor TRPVF1 and a coFexpressed receptor TRPAF1. Bronchial biopsies were obtained in 16 IPF patients, 11 chronic cough patients and 8 controls. Quantitative PCR was used to detect
APA, Harvard, Vancouver, ISO, and other styles
10

Hutchinson, John. "International comparative epidemiology of idiopathic pulmonary fibrosis." Thesis, University of Nottingham, 2017. http://eprints.nottingham.ac.uk/40715/.

Full text
Abstract:
Background Evidence from the UK suggests the incidence of idiopathic pulmonary fibrosis is increasing, but there is a lack of data from elsewhere in the World. The cause of the disease remains unknown. New anti-fibrotic therapies may increase the use of surgical lung biopsy for accurate diagnosis, although the risks of this (and other surgery) are not clear. Methods Collated international mortality statistics and a systematic review of the literature were used to assess the incidence and mortality of idiopathic pulmonary fibrosis worldwide. Primary care data from the United Kingdom were used t
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Prevention of pulmonary fibrosis"

1

Nakamura, Hiroyuki, and Kazutetsu Aoshiba, eds. Idiopathic Pulmonary Fibrosis. Springer Japan, 2016. http://dx.doi.org/10.1007/978-4-431-55582-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Meyer, Keith C., and Steven D. Nathan, eds. Idiopathic Pulmonary Fibrosis. Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-319-99975-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Meyer, Keith C., and Steven D. Nathan, eds. Idiopathic Pulmonary Fibrosis. Humana Press, 2014. http://dx.doi.org/10.1007/978-1-62703-682-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Clinical profiles of diffuse interstitial pulmonary disease. Futura Pub. Co., 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Nathan, Steven D., A. Whitney Brown, and Christopher S. King. Guide to Clinical Management of Idiopathic Pulmonary Fibrosis. Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-32794-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Bauernfeind, Adolf, Melvin I. Marks, and Birgitta Strandvik, eds. Cystic Fibrosis Pulmonary Infections: Lessons from Around the World. Birkhäuser Basel, 1996. http://dx.doi.org/10.1007/978-3-0348-7359-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Gifford, Glen Allan. A study of pulmonary lesions in experimental bovine pneumonic pasteurellosis. University of Saskatchewan, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Lewin, Linda Orkin. Pseudomonas cepacia colonization in systic fibrosis: Mortality, predictors of poor outcome, and effect on pulmonary function. s.n.], 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Parker, James N., and Philip M. Parker. Pulmonary fibrosis: A medical dictionary, bibliography, and annotated research guide to Internet references. ICON Health Publications, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Institute of Medicine (U.S.). Committee on the Elimination of Tuberculosis in the United States. Ending neglect: The elimination of tuberculosis in the United States. Edited by Geiter Lawrence. National Academy Press, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Prevention of pulmonary fibrosis"

1

Giri, S. N., and Q. Wang. "Taurine and Niacin Offer a Novel Therapeutic Modality in Prevention of Chemically-Induced Pulmonary Fibrosis in Hamsters." In Advances in Experimental Medicine and Biology. Springer US, 1992. http://dx.doi.org/10.1007/978-1-4615-3436-5_39.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Muralidharan, Priya, Don Hayes, and Heidi M. Mansour. "Pulmonary fibrosis." In Inhalation Aerosols. CRC Press, 2019. http://dx.doi.org/10.1201/9781315159768-18.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Braun-Falco, Markus, Henry J. Mankin, Sharon L. Wenger, et al. "Pulmonary Fibrosis." In Encyclopedia of Molecular Mechanisms of Disease. Springer Berlin Heidelberg, 2009. http://dx.doi.org/10.1007/978-3-540-29676-8_1496.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Bryant, Andrew J. "Pulmonary Fibrosis." In Gender, Sex Hormones and Respiratory Disease. Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-23998-9_6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Pollack, Charles V., Melissa Platt, Richard M. Cantor, Victoria G. Riese, and Jaime Friel Blanck. "Pulmonary Fibrosis." In Differential Diagnosis of Cardiopulmonary Disease. Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-319-63895-9_62.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Nguyen, J., L. Coleman, and M. Zakowski. "Pulmonary Fibrosis." In Consults in Obstetric Anesthesiology. Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-59680-8_133.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Eisenberg, Ronald L. "Pulmonary Fibrosis." In What Radiology Residents Need to Know: Chest Radiology. Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-16826-1_13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Zisman, David A., Michael P. Keane, John A. Belperio, Robert M. Strieter, and Joseph P. Lynch. "Pulmonary Fibrosis." In Fibrosis Research. Humana Press, 2005. http://dx.doi.org/10.1385/1-59259-940-0:003.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Hammar, Samuel P. "Idiopathic Interstitial Fibrosis." In Pulmonary Pathology. Springer New York, 1988. http://dx.doi.org/10.1007/978-1-4757-3932-9_18.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Hammar, Samuel P. "Idiopathic Interstitial Fibrosis." In Pulmonary Pathology. Springer New York, 1994. http://dx.doi.org/10.1007/978-1-4757-3935-0_20.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Prevention of pulmonary fibrosis"

1

Avouac, J., I. Konstantinova, C. Guignabert, et al. "OP0081 PAN-PPAR agonist IVA337 is effective in the prevention of experimental lung fibrosis and pulmonary hypertension." In Annual European Congress of Rheumatology, 14–17 June, 2017. BMJ Publishing Group Ltd and European League Against Rheumatism, 2017. http://dx.doi.org/10.1136/annrheumdis-2017-eular.3805.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Bai, D., and E. R. M. A. S. G. Jeff Crosby, Chenguang Zhao, Min Zh. "Pulmonary Delivery of NLRP3 Antisense Oligonucleotides Are Effective at Preventing but Not Reversing Established Bleomycin-Induced Pulmonary Fibrosis in Mice." In American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a4605.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Yanagi, Shigehisa, Kahori Miyoshi, Hironobu Tsubouchi, Yoshifumi Imazu, Nobuhiro Matsumoto, and Masamitsu Nakazato. "Epithelial Pten Plays An Essential Role In Preventing Pulmonary Fibrosis By Regulating The Epithelial-Mesenchymal Transition." In American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a2711.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Gerke, Alicia K., Peter Cram, Mary S. Vaughan Sarrazin, and Gary W. Hunninghake. "Survival With Pulmonary Fibrosis." In American Thoracic Society 2010 International Conference, May 14-19, 2010 • New Orleans. American Thoracic Society, 2010. http://dx.doi.org/10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a1119.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Nishimura, M., S. Ohta, K. Shinada, et al. "Electrocardiogram Signs in Idiopathic Pulmonary Fibrosis and Combined Pulmonary Fibrosis and Emphysema." In American Thoracic Society 2020 International Conference, May 15-20, 2020 - Philadelphia, PA. American Thoracic Society, 2020. http://dx.doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a3376.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Drakopanagiotakis, Fotios, Franziska Rösner, Carlo Vancheri, et al. "Non-pulmonary comorbidities in idiopathic pulmonary fibrosis." In Annual Congress 2015. European Respiratory Society, 2015. http://dx.doi.org/10.1183/13993003.congress-2015.pa2036.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Khalil, N., V. Duronio, M. Garate-Madariage, P. Hojabrpour, R. O'Connor та J. English. "Induction of p53, pRB and α-SMA by Bleomycin-Induced Lung Injury Is Abrogated by Preventing the Activation of Transforming Growth Factor- Beta1 (TGF-β1): Implications for a Therapeutic Option in Pulmonary Fibrosis". У American Thoracic Society 2020 International Conference, May 15-20, 2020 - Philadelphia, PA. American Thoracic Society, 2020. http://dx.doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a4059.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Graziani, Maria Laura, Martine Reynaud-Gaubert, Emmanuel Gomez, et al. "Pulmonary hypertension in patients with idiopathic pulmonary fibrosis and combined pulmonary fibrosis and emphysema: hemodynamic severity." In ERS International Congress 2018 abstracts. European Respiratory Society, 2018. http://dx.doi.org/10.1183/13993003.congress-2018.pa3099.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Zantah, M., Y. Dotan, C. Dass, N. Marchetti, H. Zhao, and G. J. Criner. "Patterns of Exacerbations in Combined Pulmonary Fibrosis and Emphysema versus Idiopathic Pulmonary Fibrosis." In American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3368.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Juan Samper, Gustavo, Cristina Sabater Abad, Susana Torres Martinez, et al. "Angiogenesis in idiopathic pulmonary fibrosis." In ERS International Congress 2020 abstracts. European Respiratory Society, 2020. http://dx.doi.org/10.1183/13993003.congress-2020.828.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Prevention of pulmonary fibrosis"

1

Agarwal, Sandeep K. Cadherin-11 Regulation of Fibrosis through Modulation of Epithelial-to-Mesenchymal Transition: Implications for Pulmonary Fibrosis in Scleroderma. Defense Technical Information Center, 2013. http://dx.doi.org/10.21236/ada591380.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Agarwal, Sandeep K. Cadherin-11 Regulation of Fibrosis through Modulation of Epithelial-to-Mesenchymal Transition: Implications for Pulmonary Fibrosis in Scleroderma. Defense Technical Information Center, 2014. http://dx.doi.org/10.21236/ada618226.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Swigris, Jeff, Susan Baird, Tom Vierzba, et al. Patient Participation Program for Pulmonary Fibrosis: Assessing the Effects of Supplemental Oxygen. Patient-Centered Outcomes Research Institute (PCORI), 2018. http://dx.doi.org/10.25302/11.2018.ce.12114134.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Di, Jiaqi, Xuanlin Li, Jingjing Yang, Luguang Li, and Xueqing Yu. Critical appraisal of the reporting quality of risk prediction models for idiopathic pulmonary fibrosis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2020. http://dx.doi.org/10.37766/inplasy2020.11.0105.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Li, Lijuan. Traditional Chinese Medicine For the Treatment of pulmonary fibrosis Protocol for an overview of systematic review. INPLASY - International Platform of Registered Systematic Review Protocols, 2020. http://dx.doi.org/10.37766/inplasy2020.4.0131.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Wu, Zenan, Liangji Liu, Siwen Ke, and Wei Zhu. The Baduanjin Mind-Body training improve the pulmonary functiont of patients with idiopathic pulmonary fibrosis(IPF): a protocol for systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2021. http://dx.doi.org/10.37766/inplasy2021.9.0071.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Zhang, Haoyang, Lijian Pang, Xiaodong Lv, et al. The effectiveness and safety of Chinese herbal formula for idiopathic pulmonary fibrosis: an overview of systematic reviews. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2021. http://dx.doi.org/10.37766/inplasy2021.2.0012.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Li, Lijuan, Xuan Chen, Wenna yang, et al. Traditional Chinese Medicine For the Treatment of pulmonary fibrosis: A Protocol for systematic review and meta analysis of overview. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2020. http://dx.doi.org/10.37766/inplasy2020.6.0029.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Zhang, Haoyang, Lijian Pang, Xiaodong Lv, Chuang Liu, and Minghua Nan. Multiple Traditional Chinese Medicine interventions for idiopathic pulmonary fibrosis: a protocol for systematic review and meta analysis of overview. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2020. http://dx.doi.org/10.37766/inplasy2020.8.0110.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Sun, Peng, Fei Wang, Dongmei Yan, Liping Tang, Lingxia Xu, and Bin Li. Traditional Chinese Medicines Used with modern medicine for Pulmonary Fibrosis Arising as a Sequelae in Convalescent COVID-19 Patients: a protocol for systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2021. http://dx.doi.org/10.37766/inplasy2021.6.0107.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Prevention of pulmonary fibrosis' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography